AnuhyaKommalapatiMD

Physician

Dr. Kommalapati is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Prisma Health/University of South Carolina SOM Columbia (Columbia)Residency, Internal Medicine, 2017 - 2019
Guntur Medical College NTRClass of 2013

PubMed

5 citations
Upper Limb Phlegmasia Cerulea Dolens Secondary to Heparin-induced Thrombocytopenia Leading to Gangrene.
Anuhya Kommalapati, Avyakta Kallam, Jairam Krishnamurthy, Sri Harsha Tella, Jahnavi Koppala
Cureus. 2018-06-21
8 citations
First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination.
Sri Harsha Tella, Anuhya Kommalapati, Amit Mahipal, Zhaohui Jin
Biomedicines. 2022-06-02
9 citations
Quality of life in caregivers of patients receiving chimeric antigen receptor T‐cell therapy
Anna Barata, Aasha I. Hoogland, Kelly A. Hyland, Amy K. Otto, Anuhya Kommalapati
Psycho-Oncology. 2021-04-01

Journal Articles

Predictors of Survival in Adrenocortical Carcinoma: An Analysis from the National Cancer Database (NCDB)
Electron Kebebew, Anuhya Kommalapati, The Journal of Clinical Endocrinology and Metabolism

Lectures

Outcomes following lobectomy and pneumonectomy in stage IIIA non-small cell lung cancer (NSCLC) after neoadjuvant chemoradiation.
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
Time to surgery (TTS) in renal cell carcinoma (RCC): Predictors and association with overall survival (OS).
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019